about
Major Histocompatibility Complex I Expression by Motor Neurons and Its Implication in Amyotrophic Lateral SclerosisHeterogeneity in the lymphatic vascular system and its originImmune Evasion Strategies of GlioblastomaAspects of T Cell-Mediated Immunity Induced in Mice by a DNA Vaccine Based on the Dengue-NS1 Antigen after Challenge by the Intracerebral RouteTertiary Lymphoid Organs in Central Nervous System AutoimmunityThe Kynurenine Pathway Is a Double-Edged Sword in Immune-Privileged Sites and in Cancer: Implications for ImmunotherapyLymphatics in Neurological Disorders: A Neuro-Lympho-Vascular Component of Multiple Sclerosis and Alzheimer's Disease?How Do Meningeal Lymphatic Vessels Drain the CNS?RGS2 expression predicts amyloid-β sensitivity, MCI and Alzheimer's disease: genome-wide transcriptomic profiling and bioinformatics data mining.Hello from the Other Side: How Autoantibodies Circumvent the Blood-Brain Barrier in Autoimmune Encephalitis.Single vs. combination immunotherapeutic strategies for glioma.A nested case-control study of 277 prediagnostic serum cytokines and glioma.The Role of Neutrophil Proteins on the Amyloid Beta-RAGE Axis.Tissue reservoirs of HIVCombined effect of BCG vaccination and enriched environment promote neurogenesis and spatial cognition via a shift in meningeal macrophage M2 polarization.Checking the Brain's Immune Privilege: Evolving Theories of Brain-Immune InteractionsCerebrospinal Fluid Amyloid-β 42, Total Tau, and Phosphorylated Tau are Low in Patients with Normal Pressure Hydrocephalus: Analogies and Differences with Alzheimer's Disease.Immunotherapy Combined with Large Fractions of Radiotherapy: Stereotactic Radiosurgery for Brain Metastases-Implications for Intraoperative Radiotherapy after Resection.Understanding the functions and relationships of the glymphatic system and meningeal lymphatics.Immune classifications with cytotoxic CD8+ and Th17 infiltrates are predictors of clinical prognosis in glioblastoma.Maternal Antiviral Immunoglobulin Accumulates in Neural Tissue of Neonates To Prevent HSV Neurological Disease.Immunotherapy and radiation in glioblastoma.The role of macrophage polarization on bipolar disorder: Identifying new therapeutic targets.Role of Neuro-Immunological Factors in the Pathophysiology of Mood Disorders: Implications for Novel Therapeutics for Treatment Resistant Depression.Role of the JAK/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases.Dendritic cell migration in health and disease.The role of the immune system in neurofibromatosis type 1-associated nervous system tumors.Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer's disease mice.The role of peripheral immune cells in the CNS in steady state and disease.Designer protein disaggregases to counter neurodegenerative disease.Acute and Subacute Presentations of Cerebral Edema following Deep Brain Stimulation Lead Implantation.The Microenvironmental Landscape of Brain Tumors.NKG2D ligand expression in pediatric brain tumors.Angiogenesis inhibitors in tackling recurrent glioblastoma.Myeloid Cells in the Central Nervous System.Synaptoimmunology - roles in health and disease.Role of nitric oxide in the regulation of immune responses during rabies virus infection in mice.Human and nonhuman primate meninges harbor lymphatic vessels that can be visualized noninvasively by MRI.Updates on immunity and inflammation in Parkinson disease pathology.Organ-specific protection mediated by cooperation between vascular and epithelial barriers.
P2860
Q26744608-622BD739-D5F5-46A5-B057-D7ACF550B0C3Q26746060-5948994A-39DA-441D-A84E-4ED49C1EABF2Q26765855-559D37DC-F509-42B3-9CF3-71CC8E4BD17BQ27321668-10F8246D-1F14-44B7-9E28-51D455A6A3F2Q28071379-5D14A0B6-3914-4520-BB21-B45DB8834EBEQ28073631-06CF4410-7208-412D-820D-2C2C1D5B17C7Q30275974-F647AB87-AB7C-42CF-9DC7-A03D2DA2012FQ30276270-154E56B0-F259-4DA1-A539-F1C99136CF8DQ31134674-0A5274A8-9142-4CE2-9B0B-316DE1DEE476Q33586199-1504AB2B-BDD7-4188-B6CE-69316613B52EQ33746041-D965447A-D490-443C-9EDA-4E6A931E0845Q33778545-F06EE359-E93E-416C-8A24-0CD30980414FQ36146033-80761902-DE5B-45AD-AAE7-F95D617B34BEQ37055454-BF57A78D-78F2-44EE-97A2-623C0808772DQ37635183-F2A99B43-BA9F-4900-A2F7-0585B72BCC44Q37731186-0AAD4186-29C7-4D5B-971A-4FE12BA04330Q38616051-D9073C69-5623-4671-9A01-0300D03AEEC8Q38632924-184101E1-D591-4A6B-80F8-D9B2CC941709Q38634466-406BA923-2E8D-4326-9785-D64890F7C4D6Q38691992-95D96614-C521-4A1B-80AD-B75A73D6A534Q38692329-1010D5C8-A42C-4FA0-8EF8-48C45C8997E6Q38752191-20328E9D-9C51-4B0D-88CC-702583D658F6Q38811581-C49BC8CC-AD86-4A70-9139-5E30DFCC1A50Q38966223-C96B4DE4-6E72-4BC9-A14E-E92B0A47A51BQ38974101-98BCE0A7-62D5-489C-9C71-D5F36E0BEEECQ39021691-6C66BB1A-8946-4A06-A2DC-3822E7457F71Q39045958-C665D4ED-7530-4526-A41A-D547B2B0F53FQ39076924-3D749F60-5AD4-4B6A-894B-4203A98CD8A2Q39090618-702BFAEE-431D-49C2-9514-D8371A8B49A8Q39139060-33A8AABB-A2BB-4811-9D0E-93E1BDF33608Q39139081-CC08BC79-B588-44EE-BF6C-E13ABA105275Q39178065-6757106E-DD1D-4A33-8A89-21CB584CD28CQ39196323-819448A1-99FC-47FA-901E-FE7362689759Q39259089-FAFB6CD4-A02A-4F07-9937-B11788D49CD6Q39388337-342EA6D9-51F6-432C-8A09-E2080AAC4122Q39388657-9DB1852D-EB15-4A52-9284-97C00957AF2AQ40399569-E1B1178E-2343-4712-8DC6-2CDF8559C1C3Q41843877-9C191555-0E8D-44B9-BEA9-B847673D5691Q46132067-5376014E-A3CA-440C-9A87-DC9393C7B938Q46312498-1E099DF4-A6A2-47F1-B0CD-2BAED5E32E7E
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Revisiting the Mechanisms of CNS Immune Privilege.
@ast
Revisiting the Mechanisms of CNS Immune Privilege.
@en
type
label
Revisiting the Mechanisms of CNS Immune Privilege.
@ast
Revisiting the Mechanisms of CNS Immune Privilege.
@en
prefLabel
Revisiting the Mechanisms of CNS Immune Privilege.
@ast
Revisiting the Mechanisms of CNS Immune Privilege.
@en
P2860
P50
P356
P1433
P1476
Revisiting the Mechanisms of CNS Immune Privilege.
@en
P2860
P304
P356
10.1016/J.IT.2015.08.006
P577
2015-10-01T00:00:00Z